Dr. Nanaji is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
# NBW73
Baltimore, MD 21201Phone+1 410-328-5555Fax+1 410-328-0929
Education & Training
- Indiana University School of MedicineFellowship, Hematopathology, 2007 - 2008
- University of Illinois College of Medicine at ChicagoResidency, Pathology-Anatomic and Clinical, 2003 - 2007
- Tabriz University of Medical Sciences Class of 1993
Certifications & Licensure
- MD State Medical License 2008 - 2025
- IN State Medical License 2008 - 2017
- IL State Medical License 2003 - 2014
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 10 citationsNovel eIF4A1 inhibitors with anti-tumor activity in lymphoma.Forum Kayastha, Noah B Herrington, Bandish Kapadia, Anirban Roychowdhury, Nahid Nanaji
Molecular Medicine. 2022-09-04 - 8 citationsSIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphoma.Kavita Bhalla, Sausan M. Jaber, Kayla Reagan, Arielle Hamburg, Karen F. Underwood
Scientific Reports. 2020-12-03 - 62 citationsFatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL.Bandish Kapadia, Nahid M. Nanaji, Kavita Bhalla, Binny Bhandary, Rena G. Lapidus
Nature Communications. 2018-02-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: